Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Human interleukin-10 can directly inhibit T-cell growth.

Taga K, Mostowski H, Tosato G.

Blood. 1993 Jun 1;81(11):2964-71.

2.

Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.

Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, Shearer GM.

J Clin Invest. 1993 Mar;91(3):759-65.

3.

An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status.

Landay AL, Mackewicz CE, Levy JA.

Clin Immunol Immunopathol. 1993 Oct;69(1):106-16.

PMID:
8403538
4.

CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism.

Chen CH, Weinhold KJ, Bartlett JA, Bolognesi DP, Greenberg ML.

AIDS Res Hum Retroviruses. 1993 Nov;9(11):1079-86.

PMID:
8312050
5.

HIV pathogenesis and long-term survival.

Levy JA.

AIDS. 1993 Nov;7(11):1401-10. No abstract available.

PMID:
8280406
6.

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.

Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, et al.

Science. 1994 May 13;264(5161):965-8.

PMID:
8178155
8.

Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.

Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A, Coffman RL, Shearer GM.

J Clin Invest. 1994 Feb;93(2):768-75.

9.

Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance.

Actor JK, Shirai M, Kullberg MC, Buller RM, Sher A, Berzofsky JA.

Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):948-52.

10.

TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients.

Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Meroni PL.

AIDS. 1994 Jun;8(6):757-62.

PMID:
8086133
11.
12.
13.

The Th1-Th2 hypothesis of HIV infection: new insights.

Clerici M, Shearer GM.

Immunol Today. 1994 Dec;15(12):575-81. Review.

PMID:
7848519
14.

Non-progression in HIV infection.

Easterbrook PJ.

AIDS. 1994 Aug;8(8):1179-82. No abstract available. Erratum in: AIDS 1994 Oct;8(10):1514.

PMID:
7832923
15.

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.

Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, Demarest JF, Montefiori D, Orenstein JM, Fox C, Schrager LK, et al.

N Engl J Med. 1995 Jan 26;332(4):209-16.

16.
17.

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.

Kovacs JA, Baseler M, Dewar RJ, Vogel S, Davey RT Jr, Falloon J, Polis MA, Walker RE, Stevens R, Salzman NP, et al.

N Engl J Med. 1995 Mar 2;332(9):567-75.

18.

CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription.

Mackewicz CE, Blackbourn DJ, Levy JA.

Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2308-12.

19.

Use of gelatin/plasma coated flasks for isolating human peripheral blood monocytes.

Freundlich B, Avdalovic N.

J Immunol Methods. 1983 Aug 12;62(1):31-7.

PMID:
6875265
20.

Defective T-cell colony formation and IL-2 receptor expression at all stages of HIV infection.

Winkelstein A, Kingsley LA, Klein RS, Lyter DW, Evans TL, Rinaldo CR Jr, Weaver LD, Machen LL, Schadle RC.

Clin Exp Immunol. 1988 Mar;71(3):417-22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk